Quality of Life and Self-esteem After Botox® Injections in Depressed and Non-depressed Patients
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the alterations in quality of life and
self-esteem after BOTOX® injections in the glabella in depressed and non-depressed patients.
The secondary objective of this study are:
- to assess wrinkles improvement
- to evaluate depressive symptoms using Beck Depression Inventory before and after Botox®
injections.
- to elucidate that depression is not a contraindication for botulinum toxin injections.
Phase:
Phase 4
Details
Lead Sponsor:
Brazilan Center for Studies in Dermatology
Collaborator:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA